SPECIAL NOTICE
66 -- LIFE TECHNOLOGIES, STL, 657-24-4-8544-0077 (VA-24-00057080)
- Notice Date
- 3/7/2024 12:27:50 PM
- Notice Type
- Special Notice
- NAICS
- 325413
— In-Vitro Diagnostic Substance Manufacturing
- Contracting Office
- 255-NETWORK CONTRACT OFFICE 15 (36C255) LEAVENWORTH KS 66048 USA
- ZIP Code
- 66048
- Solicitation Number
- 36C25524Q0211
- Response Due
- 3/15/2024 1:00:00 PM
- Archive Date
- 05/14/2024
- Point of Contact
- Michael P Murphy, Contract Specialist, Phone: 913-946-1963
- E-Mail Address
-
Michael.Murphy7@va.gov
(Michael.Murphy7@va.gov)
- Awardee
- null
- Description
- DISREGARD PREVIOUS VERSION OF THIS NOTIFICATION Revised Notification The Department of Veterans Affairs (VA), Network Contracting Office (NCO) 15 has a requirement to provide all the necessary supplies and reagents for sequencing COVID-19 and precision oncology using the Genexus NGS and purification system for the St. Louis VA Medical Center. The facility is located at 1 Jefferson Barracks Dr. St. Louis, MO 63125-4199. This procurement is being conducted in accordance with FAR 8.405-6; Limited Source Justification Approval and no other vendor will satisfy agency requirements. This notice of intent is not a request for competitive quotes. No solicitation documents are available and telephone requests will not be accepted. However, any firm that believes it can meet these requirements may give written notification by email to the Contracting Specialist by 3:00 PM (CST) March 15, 2024. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to comply with the above requirements. Information must be emailed to the Contracting Specialist, Michael Murphy Michael.murphy7@va.gov TELEPHONIC INQUIRIES WILL NOT BE ACCEPTED. Responses received will be evaluated; however, a determination by the Government not to compete the proposed procurement based upon responses to this notice is solely within the discretion of the Government. If no responses are received, NCO 15 will proceed with the sole source negotiation with Life Technologies. All work to be closely coordinated with the VA Contracting Officer (CO) and Contracting Officer s Representative (COR). Period of Performance: The Government anticipates a base and three (3) option periods that may be exercised at the discretion of the Government. In the subject line of any email sent, identify: 36C255-24-Q-0211 Genexus Reagents .
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/5cfddbac1c0e49ebadc69bfb40ff3e99/view)
- Record
- SN06988960-F 20240309/240307230041 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |